Dehaze, a Munich, Germany–based healthtech AI company, has secured €3.2 million in Seed funding.
Investors
The round was led by YZR Capital and DN Capital, with participation from Angel Invest, Zoho, and Better Ventures.
YZR Capital is a Munich-based venture capital firm founded in 2021 that focuses on early-stage healthcare and healthtech startups across Europe. The firm typically invests from pre-seed through Series A and selectively into later rounds, backing companies that aim to improve patient outcomes, streamline healthcare systems, and modernize medical value chains.
DN Capital is a global early-stage venture capital firm with a 25-year track record of backing category-defining technology companies. Founded in 2000, the firm operates out of London, Berlin, and Menlo Park, managing over $1 billion in assets. It primarily targets Seed and Series A investments across four core sectors: software/SaaS, fintech, marketplaces, and consumer internet.
Dehaze Use of Funds
The company will use the funding to expand engineering, research, and commercial teams, as well as accelerate product development and platform capabilities.
About Dehaze
Dehaze is a Munich-based healthtech startup developing a foundational AI model for chronic disease detection. The platform leverages causal AI to analyze large-scale, heterogeneous patient data, enabling healthcare providers and insurers to identify at-risk individuals earlier and improve intervention outcomes. By delivering actionable insights and supporting data-driven decision-making, Dehaze aims to reduce healthcare costs and improve early diagnosis rates. Its system is designed specifically for healthcare applications, focusing on traceability, scalability, and clinically relevant insights rather than generic AI outputs.
Funding Details
Company: Dehaze GmbH
Raised: €3.2M
Round: Seed
Funding Date: April 2026
Lead Investors: YZR Capital, DN Capital
Additional Investors: Angel Invest, Zoho, Better Ventures
Company Website: https://www.dehaze.de/
Software Category: Healthcare AI / Disease Detection
Source: https://tech.eu/2026/04/28/dehaze-raises-eur32m-for-ai-chronic-disease-detection/